AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2008
Dec 23, 2008
33510_dirs_2008-12-23_a7e4fbeb-2112-44a6-b473-6121f402f68b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2008-12-10
Reporting Person: Babcock Dwight William (Director, Interim CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-12-10 | Common Stock | P | 200 | $0.21 | Acquired | 63507 | Direct |
| 2008-12-11 | Common Stock | P | 800 | $0.21 | Acquired | 64307 | Direct |
| 2008-12-12 | Common Stock | P | 7300 | $0.22 | Acquired | 71607 | Direct |
| 2008-12-18 | Common Stock | P | 8900 | $0.23 | Acquired | 80507 | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16